Evaluation of the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented lesions in Asians
- PMID: 30357871
- DOI: 10.1002/lsm.23028
Evaluation of the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented lesions in Asians
Abstract
Background and objectives: Cutaneous pigmentary disorders are both more common and more difficult to treat in patients with skin color given the higher melanin content in the epidermis. Although Q-switched lasers are widely considered to be the standard treatment for both epidermal and dermal pigmentary conditions, a very high risk of post-inflammatory hyperpigmentation (PIH) of up to 25% is seen in patients with skin of color. Recently, the novel picosecond laser with pulse durations operating at sub-nanosecond domains has been shown to be effective in tattoo removal and in the treatment of acne scars. The objective of this study is to examine the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented skin lesions in Asian patients.
Methods: Twelve subjects with benign pigmentary disorders and Fitzpatrick skin types III to IV were recruited in a prospective clinical study to examine the safety and efficacy of the dual wavelength picosecond laser. Patients were treated at approximately 2-6 week intervals depending of the type of lesion. The primary efficacy endpoint is the global percent of clearance which was evaluated by blinded observers using post treatment photographs compared to baseline photographs. Safety was evaluated before and after each laser treatment and patients were asked to rate the level of pain according to the Visual Analog Scale after each treatment session. Patient satisfaction was assessed at the completion of treatment with questionnaires. All patients were followed up at 4, 8, and 12 weeks after the last treatment session.
Results: The pigmentary conditions treated included melasma, freckles, lentiginies, café au lait macules, and Hori's macules. Three months after treatment, 53.8% of all pigments achieved excellent response (75-94% lightening,) 30.8% of pigments achieved good response (50-74% lightening,) and 7.7% of pigments achieved both fair (25-49% lightening) and poor responses (0-24% lightening), respectively. The average number of treatment sessions required to reach at least 50% clearance was 4.5 for melasma, 1 for freckles, 1.5 for lentigines and 1 for café au lait. The patient with Hori's macules did not reach 50% clearance after a total of six treatments. Sixty three percent of patients reported satisfaction in the subjective assessment, while 27.3% were neutral and 9.1% were very dissatisfied. The post inflammatory hyperpigmentation rate was 4.8% and 6.5% of subjects developed blistering as a side effect of treatment.
Conclusion: The dual wavelength picosecond laser is a safe and effective treatment of benign pigmentary conditions in patients with skin of color. In particular, superior clinical efficacy is demonstrated for treatment of freckles and lentigines with a low risk of PIH. Lasers Surg. Med. 51:14-22, 2019. © 2018 Wiley Periodicals, Inc.
Keywords: Asians; picosecond; pigment; skin pigmentation.
© 2018 Wiley Periodicals, Inc.
Similar articles
-
A retrospective analysis on the management of pigmented lesions using a picosecond 755-nm alexandrite laser in Asians.Lasers Surg Med. 2016 Jan;48(1):23-9. doi: 10.1002/lsm.22443. Epub 2015 Dec 22. Lasers Surg Med. 2016. PMID: 26696500
-
Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.Lasers Surg Med. 2016 Feb;48(2):181-7. doi: 10.1002/lsm.22454. Lasers Surg Med. 2016. PMID: 26922302
-
Successful Treatment of Pigmentary Disorders in Asians With a Novel 730-nm Picosecond Laser.Lasers Surg Med. 2020 Dec;52(10):923-927. doi: 10.1002/lsm.23261. Epub 2020 May 14. Lasers Surg Med. 2020. PMID: 32410249
-
Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.Lasers Surg Med. 2017 Jan;49(1):20-26. doi: 10.1002/lsm.22518. Epub 2016 Apr 13. Lasers Surg Med. 2017. PMID: 28134994 Review.
-
The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases.Am J Clin Dermatol. 2009;10(3):153-68. doi: 10.2165/00128071-200910030-00002. Am J Clin Dermatol. 2009. PMID: 19354330 Review.
Cited by
-
Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: A randomized, controlled, assessor-blinded trial.Front Med (Lausanne). 2023 Mar 28;10:1132823. doi: 10.3389/fmed.2023.1132823. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37056729 Free PMC article.
-
Photoaging: Current Concepts on Molecular Mechanisms, Prevention, and Treatment.Am J Clin Dermatol. 2025 May;26(3):321-344. doi: 10.1007/s40257-025-00933-z. Epub 2025 Mar 12. Am J Clin Dermatol. 2025. PMID: 40072791 Review.
-
Energy-Based Skin Rejuvenation: A Review of Mechanisms and Thermal Effects.J Cosmet Dermatol. 2025 Feb;24(2):e16657. doi: 10.1111/jocd.16657. Epub 2024 Nov 1. J Cosmet Dermatol. 2025. PMID: 39485034 Free PMC article. Review.
-
Efficacy and Safety of Solid-state Dual-wavelength Lasers for the Treatment of Moderate-to-severe Inflammatory Acne in Asian Populations.Plast Reconstr Surg Glob Open. 2024 Jan 29;12(1):e5550. doi: 10.1097/GOX.0000000000005550. eCollection 2024 Jan. Plast Reconstr Surg Glob Open. 2024. PMID: 38288419 Free PMC article.
-
Effective removal of solar lentigines by combination of pre- And post-fluorescent light energy treatment with picosecond laser treatment.Clin Case Rep. 2020 Jul 11;8(8):1429-1432. doi: 10.1002/ccr3.2839. eCollection 2020 Aug. Clin Case Rep. 2020. PMID: 32884768 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources